These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Prognostic markers for stage I non-small cell lung cancer. Ohara G; Satoh H; Hizawa N Lung Cancer; 2008 Jan; 59(1):137. PubMed ID: 17996327 [No Abstract] [Full Text] [Related]
29. Effects of rhubarb extract on radiation induced lung toxicity via decreasing transforming growth factor-beta-1 and interleukin-6 in lung cancer patients treated with radiotherapy. Yu HM; Liu YF; Cheng YF; Hu LK; Hou M Lung Cancer; 2008 Feb; 59(2):219-26. PubMed ID: 17870203 [TBL] [Abstract][Full Text] [Related]
30. Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer. Schild SE; McGinnis WL; Graham D; Hillman S; Fitch TR; Northfelt D; Garces YI; Shahidi H; Tschetter LK; Schaefer PL; Adjei A; Jett J Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1106-11. PubMed ID: 16730134 [TBL] [Abstract][Full Text] [Related]
32. Prognostic markers for stage I non-small cell lung cancer. Mizuguchi S; Nishiyama N Lung Cancer; 2008 Feb; 59(2):274-5. PubMed ID: 18055061 [No Abstract] [Full Text] [Related]
33. Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting. Eberhard DA; Giaccone G; Johnson BE; J Clin Oncol; 2008 Feb; 26(6):983-94. PubMed ID: 18281673 [TBL] [Abstract][Full Text] [Related]
34. Plasma transforming growth factor beta1 as a predictor of radiation pneumonitis. Anscher MS; Kong FM; Andrews K; Clough R; Marks LB; Bentel G; Jirtle RL Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1029-35. PubMed ID: 9719112 [TBL] [Abstract][Full Text] [Related]
35. Impact of geometrical uncertainties on 3D CRT and IMRT dose distributions for lung cancer treatment. Schwarz M; Van der Geer J; Van Herk M; Lebesque JV; Mijnheer BJ; Damen EM Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1260-9. PubMed ID: 16798418 [TBL] [Abstract][Full Text] [Related]
36. Small molecular inhibitor of transforming growth factor-beta protects against development of radiation-induced lung injury. In regard to Anscher MS et al. (Int J Radiat Oncol Biol Phys 2008;71:1-9). Bahl A; Sharma DN; Rath GK; Julka PK Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):630. PubMed ID: 18793971 [No Abstract] [Full Text] [Related]
37. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial. De Ruysscher D; Bremer RH; Koppe F; Wanders S; van Haren E; Hochstenbag M; Geeraedts W; Pitz C; Simons J; ten Velde G; Dohmen J; Snoep G; Boersma L; Verschueren T; van Baardwijk A; Dehing C; Pijls M; Minken A; Lambin P Radiother Oncol; 2006 Sep; 80(3):307-12. PubMed ID: 16949169 [TBL] [Abstract][Full Text] [Related]
38. [The estimation of serum concentration of vascular endothelial growth factor in patients with non-small cell lung cancer]. Kopczyńska E; Dancewicz M; Kowalewski J; Kardymowicz H; Tyrakowski T Pol Merkur Lekarski; 2007 Jun; 22(132):536-8. PubMed ID: 17874624 [TBL] [Abstract][Full Text] [Related]
39. Phase I/II trial of sequential chemoradiotherapy using a novel hypoxic cell radiosensitizer, doranidazole (PR-350), in patients with locally advanced non-small-cell lung Cancer (WJTOG-0002). Nishimura Y; Nakagawa K; Takeda K; Tanaka M; Segawa Y; Tsujino K; Negoro S; Fuwa N; Hida T; Kawahara M; Katakami N; Hirokawa K; Yamamoto N; Fukuoka M; Ariyoshi Y Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):786-92. PubMed ID: 17512126 [TBL] [Abstract][Full Text] [Related]